MedTrace Logo

Withdrawal of Medication in Recovered DCM

NCT02770443 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-01-23

No results posted yet for this study

Summary

Randomized study of medication withdrawal in patients who have recovered LV function in Dilated Cardiomyopathy.

Conditions

  • Dilated Cardiomyopathy

Interventions

DRUG

withdrawal

withdrawal of beta blocker and ACE inhibitors

DRUG

standard of CARE

STANDARD OF CARE, NO WITHDRAWAL OF MEDICAL THERAPY

Sponsors & Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    collaborator OTHER

  • Jewish General Hospital

    collaborator OTHER

  • McGill University

    lead OTHER

Principal Investigators

  • Nadia Giannetti, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-19
Primary Completion
2017-08-24
Completion
2019-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02770443 on ClinicalTrials.gov